MedPath

MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial

Not Applicable
Completed
Conditions
Borderline Personality Disorder
Interventions
Behavioral: Treatment As Usual
Behavioral: Mentalization Based Treatment
Registration Number
NCT02068326
Lead Sponsor
Psychiatric Research Unit, Region Zealand, Denmark
Brief Summary

Background: Although it is now possible to diagnose Borderline Personality Disorder (BPD) in adolescents younger than 18 years according to the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V), and studies indicates that BPD can be reliably diagnosed in adolescence, only a few evidence based treatment programmes for adolescent BPD exists. Mentalization-based treatment (MBT), including group psychotherapy, has repeatedly shown to be effective in treating adult BPD, but in the case of adolescents, only individual MBT have been tested and found to be effective.

Aims/hypotheses: We will test whether group based MBT (MBT-G), including an introductory programme for patients (MBT-I) and their parents (MBT-P) is more effective than Treatment As Usual (TAU) in treating adolescents with BPD or subthreshold BPD.

Methods/Design: 112 patients referred to child and adolescent psychiatric clinics in Region Zealand will be randomized to either MBT or TAU. Inclusion criteria: Meeting DSM-V BPD-criteria at the threshold (five criteria) or sub threshold level (4 criteria). Follow-up will be at three and 12 months.

Discussion: Early intervention is especially important in relation to personality psychopathology and has long-term benefits for patients, their families and society. In addition to being cost effective, using the group modality in the treatment of BPD may have several advantages. This is the first Randomized Controlled Trial (RCT) to test the effectiveness of MBT in groups for adolescents.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
112
Inclusion Criteria
  • Meet a minimum of 4 DSM-5 BPD criteria
  • Have parent's or parent substitute's commitment and ability to participate in the MBT-Parents program.
  • Score 67< BPFS-C
Exclusion Criteria
  • Comorbid diagnosis of pervasive developmental disorder, learning disability (75 < IQ), anorexia, current psychosis, diagnosis of schizophrenia or schizotypal personality disorder, antisocial personality disorder as well as any other axis-I or axis-II psychopathology considered to be the primary diagnosis.
  • Current psychiatric inpatient treatment
  • Current (past two months) substance dependence (but not substance misuse)
  • Participation in concurrent psychotherapeutic treatment outside the MBT program
  • Not able to speak Danish
  • Lack of informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Treatment As UsualTreatment As UsualParticipants randomized to the control group will receive Treatment As Usual (TAU). TAU is defined as comprising at least 12 monthly individual supportive sessions provided by non-MBT trained mental health professionals in the Department of Child and Adolescent Psychiatry in Region Zealand. Additional supportive sessions or other types of intervention may be offered to the patients according to the needs of the patients as evaluated by mental health professionals responsible for his/hers treatment. Hence, TAU may vary considerably in number and type of intervention across clinics and patients. All mental health services delivered during the treatment period to patients in the TAU group will be monitored and registered.
Mentalization Based TreatmentMentalization Based Treatmentthe experimental intervention is a year-long manualized program that comprises four components: * Five individual case-formulation sessions, * MBT-I, an introductory pedagogical program for patients (three weekly sessions) * MBT-G, MBT-program in groups (37 weekly sessions) * MBT-P, a psychoeducation program for the patients' parents or parents substitutes (six sessions).
Primary Outcome Measures
NameTimeMethod
The Borderline Personality Feature Scale for Children (BPFS-C)Change from baseline at 30 weeks
Secondary Outcome Measures
NameTimeMethod
The Childrens' Global Assessment Scale (CGAS)Change from baseline at 40 weeks
The childhood behaviour checklist (CBCL, Parental outcome measure)Change from baseline at 30 weeks
The borderline personality feature scale for Children - parental version (BPFS-P)Change from baseline at 30 weeks
Number of patients' hospital admissions and visits to the emergency roomChange from baseline at 40 weeks
The Youth Self-Report (YSR)Change from baseline at 40 weeks
Becks Depression Inventory for YouthChange from Baseline in at 40 weeks
The Risk-Taking and Self-Harm Inventory for adolescents (RTSHIA)Chage from baseline at 30 weeks
ZAN-BPD Zanarini Rating Scale for Borderline Personality DisorderChange from baseline at 40 weeks
The Health of the Nation Outcome Scale for Children and Adolescent (HoNOSCA)Change from baseline at 40 weeks

Trial Locations

Locations (1)

Child and Adolescent Psychiatric Department, Region Zealand

🇩🇰

Roskilde, Region Zealand, Denmark

© Copyright 2025. All Rights Reserved by MedPath